Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A2402 mice von Tanaka, Yuki, Wada, Hiroshi, Goto, Risa, Osada, Toshihiro, Yamamura, Keisuke, Fukaya, Satoshi, Shimizu, Atsushi, Okubo, Mitsuru, Minamiguchi, Kazuhisa, Ikizawa, Koichi, Sasaki, Eiji, Utsugi, Teruhiro

Volltext

TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A2402 mice von Tanaka, Yuki, Wada, Hiroshi, Goto, Risa, Osada, Toshihiro, Yamamura, Keisuke, Fukaya, Satoshi, Shimizu, Atsushi, Okubo, Mitsuru, Minamiguchi, Kazuhisa, Ikizawa, Koichi, Sasaki, Eiji, Utsugi, Teruhiro

Volltext

TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer von Yoshida, Shohei, Kajiwara, Daisuke, Seki, Masanao, Tayama, Manabu, Tanaka, Yuki, Mizutani, Hiroya, Fujita, Ryoto, Yamamura, Keisuke, Okajima, Shigeo, Asai, Masanori, Minamiguchi, Kazuhisa

Volltext

Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell‐induced angiogenesis von Minamiguchi, Kazuhisa, Kumagai, Hiroyuki, Masuda, Tohru, Kawada, Manabu, Ishizuka, Masaaki, Takeuchi, Tomio

Volltext

Inhibitory Activity of the Hypoxia-inducible Factor-1 Pathway by Tartrolone C von Yamazaki, Yohko, Someno, Tetsuya, Minamiguchi, Kazuhisa, Kawada, Manabu, Momose, Isao, Kinoshita, Naoko, Doi, Hiroyasu, Ikeda, Daishiro

Volltext

TAS 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer von Yoshida, Shohei, Kajiwara, Daisuke, Seki, Masanao, Tayama, Manabu, Tanaka, Yuki, Mizutani, Hiroya, Fujita, Ryoto, Yamamura, Keisuke, Okajima, Shigeo, Asai, Masanori, Minamiguchi, Kazuhisa

Volltext

A Microplate Assay for Selective Measurement of Growth of Epithelial Tumor Cells in Direct Coculture with Stromal Cells von KAWADA, Manabu, YOSHIMOTO, Yuya, MINAMIGUCHI, Kazuhisa, KUMAGAI, Hiroyuki, SOMENO, Tetsuya, MASUDA, Tohru, ISHIZUKA, Masaaki, IKEDA, Daishiro

Volltext

Analysis of novel enzalutamide-resistant cells: upregulation of testis-specific Y-encoded protein gene promotes the expression of androgen receptor splicing variant 7 von Seki, Masanao, Kajiwara, Daisuke, Mizutani, Hiroya, Minamiguchi, Kazuhisa

Volltext

TAS3681, a novel type of AR antagonist with AR downregulating activity, as a new targeted therapy for aberrant AR-driven prostate cancer von Seki, Masanao, Minamiguchi, Kazuhisa, Kajiwara, Daisuke, Mizutani, Hiroya, Yoshida, Shohei, Sasaki, Eiji, Utsugi, Teruhiro, Iwasawa, Yoshikazu

Volltext

The impact of TAS3681, a new type of androgen receptor antagonist, on aberrant AR signaling that drives tumor resistance to AR-targeted therapies by down-regulating full length and... von Kajiwara, Daisuke, Minamiguchi, Kazuhisa, Seki, Masanao, Mizutani, Hiroya, Yamamura, Keisuke, Okajima, Shigeo, Sasaki, Eiji, Utsugi, Teruhiro, Iwasawa, Yoshikazu

Volltext

Effect of a new type androgen receptor antagonist, TAS3681, on ligand-independent AR activation through its AR downregulation activity von Kajiwara, Daisuke, Minamiguchi, Kazuhisa, Seki, Masanao, Mizutani, Hiroya, Aoyagi, Hiroki, Okajima, Shigeo, Sasaki, Eiji, Utsugi, Teruhiro, Iwasawa, Yoshikazu

Volltext

Abstract PR09: TAS3681, a new type androgen receptor antagonist, suppresses ligand-independent AR activation through its AR downregulation activity von Kajiwara, Daisuke, Minamiguchi, Kazuhisa, Seki, Masanao, Mizutani, Hiroya, Aoyagi, Hiroki, Okajima, Shigeo, Sasaki, Eiji, Utsugi, Teruhiro, Iwasawa, Yoshikazu

Volltext

TAS3681: New class of androgen receptor antagonist with androgen receptor downregulating activity von Minamiguchi, Kazuhisa, Seki, Masanao, Aoyagi, Hiroki, Kajiwara, Daisuke, Mori, Tomoko, Masuko, Norio, Fujita, Ryouto, Okajima, Shigeo, Hayashi, Yukio, Sasaki, Eiji, Utsugi, Teruhiro

Volltext

VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia von Mori, Fumitaka, Tanigawa, Kiyoshi, Endo, Kanji, Minamiguchi, Kazuhisa, Abe, Masaaki, Yamada, Shizuo, Miyoshi, Kazuhisa

Volltext

RECOMBINANT ALKALINE SERINE PROTEASE II DEGRADES SCRAPIE ISOFORM OF PRION PROTEIN von HUI, ZHAO, MINAMIGUCHI, KAZUHISA, DOI, HIROYASU, KINOSHITA, NAOKO, KANOUCHI, HIROAKI, OKA, TATSUZO

Volltext

Abstract 2625: MGCD0103, an oral isotype-selective HDAC inhibitor, has antitumor activity via the induction of the expression of Annexin A1 on AML1/ETO AML in vitro and in vivo von Nameki, Daisuke, Masuko, Norio, Fujita, Ryouto, Sugiura, Shin, Yamamoto, Yasuji, Minamiguchi, Kazuhisa, Matsuo, Ken-Ichi

Volltext

VAT-I Is a Novel Pathogenic Factor of Progressive Benign Prostatic Hyperplasia von MORI, Fumitaka, TANIGAWA, Kiyoshi, ENDO, Kanji, MINAMIGUCHI, Kazuhisa, ABE, Masaaki, YAMADA, Shizuo, MIYOSHI, Kazuhisa

Volltext

Abstract B1: Antitumor activity of TSU-68 in PDGF-BB overexpressing U-87MG xenograft model: contribution of PDGFR blocking action von Hosoi, Fumihito, Yokoi, Hiromi, Nameki, Daisuke, Hayashi, Hiroaki, Ito, Kenjiro, Masuko, Norio, Minamiguchi, Kazuhisa, Matsuo, Ken-ichi, Utsugi, Teruhiro

Volltext

Abstract 4108: Syndecan-1 overexpression enhances colon cancer growth by modulating heparan sulfate binding growth factors sensitivity von Hayashi, Hiroaki, Minamiguchi, Kazuhisa, Kanoh, Akira, Ishida, Keisuke, Terada, Tadashi, Matsuo, Kenichi

Volltext

Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness von Minamiguchi, Kazuhisa, Kawada, Manabu, Someno, Tetsuya, Ishizuka, Masaaki

Volltext